Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TACROLIMUS Cause Hepatic failure? 372 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 372 reports of Hepatic failure have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.4% of all adverse event reports for TACROLIMUS.

372
Reports of Hepatic failure with TACROLIMUS
0.4%
of all TACROLIMUS reports
268
Deaths
218
Hospitalizations

How Dangerous Is Hepatic failure From TACROLIMUS?

Of the 372 reports, 268 (72.0%) resulted in death, 218 (58.6%) required hospitalization, and 96 (25.8%) were considered life-threatening.

Is Hepatic failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 372 reports have been filed with the FAERS database.

What Other Side Effects Does TACROLIMUS Cause?

Off label use (8,718) Drug ineffective (6,214) Product use in unapproved indication (5,057) Acute kidney injury (4,005) Transplant rejection (3,526) Cytomegalovirus infection (3,320) Covid-19 (3,201) Drug interaction (2,896) Diarrhoea (2,854) Toxicity to various agents (2,845)

What Other Drugs Cause Hepatic failure?

ACETAMINOPHEN (1,392) RIBAVIRIN (888) CYCLOPHOSPHAMIDE (629) METHOTREXATE (598) BEVACIZUMAB (558) SOFOSBUVIR (525) RITUXIMAB (513) VINCRISTINE (468) DOXORUBICIN (462) PREDNISOLONE (425)

Which TACROLIMUS Alternatives Have Lower Hepatic failure Risk?

TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS TACROLIMUS vs TADALAFIL TACROLIMUS vs TAFAMIDIS TACROLIMUS vs TAFAMIDIS MEGLUMINE TACROLIMUS vs TAFASITAMAB

Related Pages

TACROLIMUS Full Profile All Hepatic failure Reports All Drugs Causing Hepatic failure TACROLIMUS Demographics